健常人における Isosorbide-5-mononitrate (TY-10368) の単回ならびに反復経口投与後の体内動態-摂食による影響および血漿中 Cyclic GMP濃度への影響
スポンサーリンク
概要
- 論文の詳細を見る
Plasma concentrations of isosorbide-5-mononitrate (5-ISMN) (TY-10368) measured: (1) after oral doses of 10 mg at fasting or at 1.5 hr after meal in 3 subjects with one week between dosing sessions, (2) after oral doses of 10, 20 40 mg in 6 subjects and (3) after repeated oral doses of 20 mg at 12-hr intervals 84 hr in 6 subjects. Food intake reduced the peak plasma concentrations of ISMN, but did not affect the extent of bioavailability from oral dosing after an overnight fast. Maximum plasma concentrations were achieved within the same range time after all doses: an average of 1.7 hr±0.2 (SD; non-fasting). The pharmaco-kinetics showed dose-lineality, since the peak plasma concentrations and the total area under the curve (AUC) were proportional to dose administered. The elim ination half-lives after administration of all doses were in the range of 5-6 hr, with narrow interindividual variation. The total amounts of free and conjugated 5-ISMN excreted into the urine over 60 hr were proportional to dose administered within a range of 22-36%, and only a trace amount was detected at 24 hr after dose.<BR>Repeated administration at 12-hr intervals during 84 hr did not increase the minimal plasma concentration or elimination half-life without significant increase of time to peak plasma concentration.<BR>Whereas the diastolic blood pressure did not change systematically, average falls in the systolic blood pressure of 6.2%, 10.3% and 12.3% were observed at the time of the peak plasma levels after single oral dose of 10, 20 and 40 mg, respectively. There was no significant correlation between maximum plasma 5-ISMN levels and corresponding systolic blood pressure reduction.<BR>The plasma cyclic GMP concentrations determined when the peak 5-ISMN plasma levels were achieved or when the maximal systolic blood pressure reductions were noted, decreased significantly after oral doses of 20 mg, but the highest dose did not change the plasma cyclic GMP levels significantly.<BR>All subjects complained of a headache or felt heavy-headedness which did not seem to be dose-dependent, and mentioned no symptoms at 24 hr after TY-10368 administration.
- 一般社団法人 日本臨床薬理学会の論文
著者
-
松岡 功
福島県立医科大学薬理学教室
-
千田 敏
トーアエイヨー株式会社福島研究所
-
田原 一二
福島県立医科大学薬理学教室
-
木村 哲夫
トーアエイヨー (株) 福島研究所
-
田中 修
トーアエイヨー (株) 福島研究所
-
松岡 功
福島県立医科大学医学部薬理学講座
-
千田 敏
トーアエイヨー (株) 福島研究所
関連論文
- トロンビン刺激血管内皮細胞のRhoA活性化におけるゲラニルゲラニル化の重要性(第139回日本循環器学会東北地方会)
- 循環器機能におよぼすニコチンと喫煙の作用
- P-385 片側妊娠ラット子宮筋におけるadenylyl cyclaseの遺伝子発現と収縮反応
- P-178 ラット子宮筋におけるadenylyl cyclase遺伝子発現の性ホルモンによる影響
- Effect of Verapamil Derivative(TY-10835) on Spontaneous Action Potentials in Isolated Rabbit Sinoatrial Node
- ヒト星状神経細胞種培養株1321N1のIMPase活性に対するリチウムとPMA長時間処理の影響
- 神経系におけるエクトヌクレオチダーゼ
- ATP受容体を介する細胞応答と細胞外ATP代謝酵素の役割
- ニコチンによるアデニル酸シクラーゼ発現調節
- ニコチンによるアデニル酸シクラーゼ発現調節
- 6th International Symposium on Adenosine and Adenine nucleotidesに参加して
- モルヒネの薬物依存 : オピオイド受容体と依存形成の分子機構 (依存)
- Effect of Duloxetine on Isolated Rabbit Detrusor Muscle
- NG108-15細胞のATPにより誘発される非選択性陽イオン電流
- 特異的抗血清を用いるラジオイムノアッセイによる血漿中 Dihydroergotoxine の測定
- ATP受容体の情報伝達機構解析モデルとしてのNG108-15細胞の性質
- 健常人における Isosorbide-5-mononitrate (TY-10368) の単回ならびに反復経口投与後の体内動態-摂食による影響および血漿中 Cyclic GMP濃度への影響
- タイトル無し
- Studies on transdermal absorption of isosorbide dinitrate tape.
- Ecto-nucleotidases in the Nerves System